HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A case of Guillain-Barré syndrome treated with plasma exchange and intravenous high-dose immune globulin].

Abstract
We describe a 69-year-old female with Guillain-Barré syndrome (GBS) whose paresthesia and weakness improved after plasma exchange (PE) and intravenous high-dose immune globulin (i.v.I.G.). She felt a paresthesia in her right arm, and 7 days later she noticed right arm weakness followed by gait disturbance within 2 days. She received a series of 6 PEs, but paresthesia and weakness did not improve. Following the last PE trial of this series, she was treated by i.v.I.G. (0.4 g/kg) for 5 days. After i.v.I.G., paresthesia and weakness improved in a few days. After 2nd series of 6 PEs, she was able to walk. In this clinical course, the treatment of i.v.I.G. after PE seemed to be effective. This case raises the possibility that i.v.I.G. might be the treatment in GBS patients with insufficient effect of PE.
AuthorsN Imai, K Miyata, Y Terayama, N Ishihara
JournalRinsho shinkeigaku = Clinical neurology (Rinsho Shinkeigaku) Vol. 37 Issue 6 Pg. 520-2 (Jun 1997) ISSN: 0009-918X [Print] Japan
PMID9366182 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Immunoglobulins, Intravenous
Topics
  • Aged
  • Female
  • Humans
  • Immunoglobulins, Intravenous (administration & dosage)
  • Plasma Exchange
  • Polyradiculoneuropathy (physiopathology, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: